Distributors Processing, Inc.
Porterville, CA, US· latest recorded location
Distributors Processing, Inc. is named on 5 US grants and 3 published applications in this corpus. Its most frequent classification is A23K (Fodder).
- Granted patents
- 5
- Published applications
- 3
- Inventors
- 3
- Granted in 2026 so far
- 0
- Most recent grant
- 12 May 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 1 |
| 2020 | 1 | 1 |
By publication year.
Technology areas
Share of 8 documents
Recent patents
- Use of zinc and copper gluconate in the treatment of methicillin-resistant Staphylococcus aureus12 May 2020US 10,645,953 B2
- Oral use of zinc and copper gluconates in the treatment of digital dermatitis1 Jan 2019US 10,166,212 B2
- Steroidal sapogenins for the control of coccidiosis in animals27 May 2003US 6,569,843 B1
- Yucca extract grain tempering mixture and process20 Sep 1988US 4,772,479 A
- Yucca extract grain tempering mixture and process14 Apr 1987US 4,657,766 A
- Use of zinc and copper gluconate in the treatment of methicillin-resistant staphylococcus aureus27 Aug 2020US 2020/0268019 A1
- Use of zinc and copper gluconate in the treatment of methicillin-resistant staphylococcus aureus18 Apr 2019US 2019/0110499 A1
- Oral use of zinc and copper gluconates in the treatment of digital dermatitis21 Jun 2018US 2018/0169056 A1
Most cited
By later US patents